CDEK
← All drugs Report issue

cetrelimab

mAbexperimental

Clinical trial activity

20 trials · 8 clinical orgs · 0 marketing orgs

Phase 1
11
Phase 2
11
Phase 3
3
Phase 4
0

Earliest trial started Nov 21, 2016 (NCT02908906)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • jnj-63723283

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07027514Phase 1Oct 22, 2025Ankyra Therapeutics, Inc
NCT06534190Phase 2Aug 31, 2024University of Groningen
NCT06311578Phase 1Apr 10, 2024Johnson and Johnson
NCT06116786Phase 1Nov 27, 2023Johnson and Johnson
NCT05908734Phase 1/Phase 2 (Phase 2)May 18, 2023—
NCT05818683Phase 1Apr 26, 2023—
NCT05714202Phase 3Mar 23, 2023—
NCT06511648Phase 2Mar 7, 2023Johnson and Johnson, Pivotal S.L., Spanish Oncology Genito-Urinary Group
NCT05242445Phase 1Apr 19, 2022Johnson and Johnson
NCT04926181Phase 2Dec 15, 2021Janssen Pharmaceutica NV, University of California, San Francisco
NCT04919512Phase 2Nov 15, 2021Janssen Pharmaceutica NV
NCT04640623Phase 2Dec 17, 2020Janssen Pharmaceutica NV
NCT04658862Phase 3Dec 7, 2020Janssen Pharmaceutica NV
NCT04592237Phase 2Nov 30, 2020University of Texas at Houston
NCT03547037Phase 1Aug 31, 2018Janssen Pharmaceutica NV
NCT03551782Phase 1Jun 28, 2018Johnson and Johnson
NCT03473743Phase 1/Phase 2 (Phase 2)Apr 5, 2018Johnson and Johnson
NCT03431350Phase 1/Phase 2 (Phase 2)Mar 2, 2018Janssen Pharmaceutica NV
NCT03357952Phase 2/Phase 3 (Phase 3)Nov 16, 2017Johnson and Johnson
NCT02908906Phase 1Nov 21, 2016Johnson and Johnson
Showing 20 of 20 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Johnson and JohnsonFor profit8632016
Janssen Pharmaceutica NVFor profit6532018
Ankyra Therapeutics, IncFor profit1112025
Pivotal S.L.For profit1012023
Spanish Oncology Genito-Urinary GroupAcademic/Hospital1112023
University of California, San FranciscoAcademic/Hospital1112021
University of GroningenAcademic/Hospital1112024
University of Texas at HoustonAcademic/Hospital1112020
8 organizations
Page 1 / 1